Markets:

Overview

News

Currencies

International

Treasuries

Amgen (NQ:AMGN)

343.99 +2.28 (+0.67%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 18, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Amgen

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

60 61 Next >

Don’t Confuse Brains With A Bull Market, Or Price With Value ↗

November 10, 2024

If you are interested in the stock market, maybe it is time to stop focusing on The Fed.

Via Talk Markets

Investors Like Certainty. Trump's Win Gave Them Some. ↗

November 08, 2024

We're also talking about Super Micro, Nvidia, and weight loss.

Via The Motley Fool

Topics Government

AstraZeneca/Amgen's Asthma Drug Aces Late-Stage Study In Patients With Chronic Rhinosinusitis ↗

November 08, 2024

AstraZeneca and Amgen's Phase 3 trial data shows Tezspire significantly reduces nasal polyps and congestion in patients with chronic rhinosinusitis with nasal polyps.

Via Benzinga

3 Healthcare Stocks For Long-Term Growth And Dividends ↗

November 07, 2024

Healthcare stocks will profit from the U.S. aging population and pay rising dividends over time.

Via Talk Markets

Upstream Bio Is New On NASDAQ, Can Potentially Beat AstraZeneca's Asthma Drug On Efficacy, Analysts Say ↗

November 05, 2024

Upstream Bio garners analyst optimism for its lead drug verekitug, which could disrupt the $7.5 billion asthma biologics market.

Via Benzinga

A Closer Look at Amgen's Options Market Dynamics ↗

October 23, 2024

Via Benzinga

Navigating 14 Analyst Ratings For Amgen ↗

October 22, 2024

Via Benzinga

Is Amgen Stock a Buy? ↗

October 18, 2024

This biotech leader could be poised to rally higher.

Via The Motley Fool

10 Health Care Stocks Whale Activity In Today's Session ↗

November 05, 2024

Via Benzinga

Stock Market Retreats Before Election Day; Microsoft, Apple, Amazon, Google, Meta In Focus: Weekly Review ↗

November 01, 2024

The major indexes declined, but haven't fallen apart.

Via Investor's Business Daily

Amgen (AMGN) Q3 2024 Earnings Call Transcript ↗

October 30, 2024

AMGN earnings call for the period ending September 30, 2024.

Via The Motley Fool

Topics Earnings

Looking Into Amgen's Recent Short Interest ↗

October 17, 2024

Via Benzinga

In-Depth Examination Of 11 Analyst Recommendations For Amgen ↗

October 14, 2024

Via Benzinga

Stocks Tumble, Nasdaq 100 Selloffs As Tech Giants Disappoint, Crypto Companies Plummet: What's Driving Markets Thursday? ↗

October 31, 2024

Risk aversion swept across markets on Thursday as investor disappointment over third-quarter tech earnings triggered the steepest drop in major U.S. indices in nearly two months.

Via Benzinga

Amgen 'Laser-Focused' On Its Weight-Loss Shot As New Rival Pfizer Follows, Says CFO ↗

October 30, 2024

The company expects to have topline results from a Phase 2 study later this year.

Via Investor's Business Daily

Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights ↗

October 30, 2024

Novartis aims to enhance Pluvicto's market presence while exploring growth in multiple sclerosis and expanding its radioligand therapy portfolio.

Via Benzinga

Wall Street Mixed, Semiconductors Tumble As AMD Disappoints, Alphabet Rallies, SMCI Plummets: What's Driving Markets Wednesday? ↗

October 30, 2024

Wall Street experienced a mixed trading session on Wednesday as investors weigh a batch of corporate earnings and fresh economic data.

Via Benzinga

Stock-Split Watch: 2 Healthcare Stocks That Look Ready to Split ↗

October 28, 2024

One of these players has split its stock in the past. The other one hasn't.

Via The Motley Fool

What Lies In Store For Healthcare ETFs In Q3 Earnings? ↗

October 27, 2024

The healthcare sector has performed well in recent months, driven by the booming weight-loss drug treatment segment. As such, various healthcare ETFs have benefited.

Via Talk Markets

Topics ETFs

2 Reliable Dividend Stocks You Can Buy and Hold Forever ↗

October 26, 2024

There are reasons beyond the dividends to invest in these stocks.

Via The Motley Fool

Top Stock Reports For Costco, Coca-Cola & T-Mobile US ↗

October 25, 2024

Today's Research Daily features new research reports on 16 major stocks, including Costco Wholesale Corp., The Coca-Cola Co., and T-Mobile US, Inc., as well as a micro-cap stock Preformed Line Products...

Via Talk Markets

Roche's Q3 Sales Surge Led By Ocrevus, Vabysmo, Urges Regulators To Block Novo Holdings' $16.5B Catalent Acquisition ↗

October 23, 2024

Roche reported a 9% increase in third-quarter sales, driven by strong performance from Ocrevus and Vabysmo. Roche also raised concerns over the Catalent acquisition.

Via Benzinga

Why Amgen's Obesity Drug — And $5 Billion Opportunity — Led To A Downgrade ↗

October 14, 2024

The analyst is closely watching MariTide, a potential monthly injection to treat obesity.

Via Investor's Business Daily

Blue Skies, New Highs Remain Disciplined And Do Not Chase Extended Ideas ↗

October 13, 2024

It is Fall clean up time. Sell lagging and sagging companies.

Via Talk Markets

Novo Nordisk, Eli Lilly Could Face Downward Pressure Despite Market Dominance From Potentially 16 New Obesity Drugs: See The Names ↗

October 11, 2024

The $200B GLP-1 market is set to expand with 16 new obesity drugs launching by 2029, challenging Novo Nordisk and Eli Lilly's dominance while addressing scalability and pricing concerns.

Via Benzinga

2 Top Dividend Stocks to Buy Hand Over Fist Right Now ↗

October 11, 2024

Income stocks can be wise additions to your portfolio in any market environment.

Via The Motley Fool

18 Stocks To Buy, 7 To Sell This Earnings Season: Goldman Sachs Calls It 'The Year Of The Stock Picker' ↗

October 10, 2024

Goldman Sachs identifies 18 stocks for potential earnings upside and advises options-based strategies in a volatile market. 10% upside for S&P 500.

Via Benzinga

Topics Stocks

Deere, Amgen, Copart And More: CNBC's 'Final Trades' ↗

October 10, 2024

On CNBC's "Halftime Report Final Trades," Jim Lebenthal of Cerity Partners named Deere & Company as his final trade.

Via Benzinga

Biden Administration Unveils Plan To Provide Generic Drugs for $2 to Medicare Recipients ↗

October 09, 2024

The Biden administration's proposed Medicare $2 Drug List Model aims to provide low-cost generic drugs for seniors and people with disabilities, with copayments capped at $2 per month for essential...

Via Benzinga

2 Biotech Stocks to Buy Hand Over Fist in October ↗

October 09, 2024

These longtime leading biotech stocks still have plenty of upside ahead.

Via The Motley Fool

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

60 61 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.